ANDA intelligence board

Control source watch, CMC evidence, deficiency risk, launch readiness, and decision packets.

One working surface for the highest-value generics gaps: FDA/PSG/Orange Book source posture, Module 3 CMC narrative authoring, likely agency questions, nitrosamine and impurity risk, supplier qualification, launch readiness, and Program OS packet export.

Start Source Watch Build Decision Packet
Decision-support workspace. Final ANDA, CMC, safety, quality, patent, and market decisions require current source review and authorized SME, QA, regulatory, and legal signoff.
FDA / PSG / Orange Book

Source-watch dashboard

FDA Orange Book FDA PSGs Orange Book data files
Module 3 evidence composer

CMC narrative sections

Deficiency response simulator

Likely agency questions

Nitrosamine and impurity risk

Risk workspace

FDA nitrosamine information
Supplier qualification

API/excipient scoring

ANDA launch readiness

Filing, patent, supply, pricing, and quality board

76
64
70
74
78
Decision packet export

Board and regulatory summaries

Board summary

Build a decision packet after scoring the sections.

Regulatory summary

Build a decision packet after scoring the sections.

Packet JSON

{}